Stratasys Offers an Inviting Pullback

 | Jul 10, 2013 | 7:00 AM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

ssys

I like this pullback in Stratasys (SSYS) for a buy for a few reasons. First, I have higher targets based on the current pattern of this stock. If the current pattern remains intact, the first meaningful upside targets in this one come in at the $100.44-$101.03 area.

The swings that identify these targets are labeled on the daily chart below. For the bullish pattern in Stratasys to remain intact, price needs to hold above the $77.79 swing low.

Second, price is above the 200- and 50-day simple moving averages, and it's still on a "buy," with the 5 ema holding above the 13 ema. These averages are technical "filters" I like to use that support this bullish scenario. Third, I have two Fibonacci price cluster zones that include symmetry projections. They come in at $85.12-$87.54 and then $82.15-$83.98. If Stratasys is going to continue higher, I would like to see it hold above one of these zones.

Remember that the markets will typically ebb and flow. After the recent pop in this stock, up to a 1.618 extension, you can see the pullback zones that I've projected from that recent high. Rather than buying new highs like we saw a couple days ago, a better way to go, in my opinion, is to keep the edge by buying the pullbacks after the new highs. So here we have a pullback that looks very interesting to me, with the risk pretty well defined.

Bottom line, I am long a call spread in this one, looking for that $100 area target. I will consider myself wrong if the second price cluster identified on this chart is taken out on the downside.

Columnist Conversations

Paul - The BRLI looks like just a bad 100 share trade out of over 10,000 shares traded. I would put no weight ...
Sometimes we just want to look at charts... this will be the first in a series of just that. Today we observe...
Laboratory testing company Bio-Reference Labs (BRLI) was up 5.66%, at $33.58, as of 5:37 PM. EPS are due out ...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.